» Articles » PMID: 35185877

The HVEM-BTLA Immune Checkpoint Restrains Murine Chronic Cholestatic Liver Injury by Regulating the Gut Microbiota

Overview
Journal Front Immunol
Date 2022 Feb 21
PMID 35185877
Authors
Affiliations
Soon will be listed here.
Abstract

The herpes virus entry mediator (HVEM) is an immune checkpoint molecule regulating immune response, but its role in tissue repair remains unclear. Here, we reported that HVEM deficiency aggravated hepatobiliary damage and compromised liver repair after 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced injury. A similar phenotype was observed in B and T lymphocyte attenuator (BTLA)-deficient mice. These were correlated with impairment of neutrophil accumulation in the liver after injury. The hepatic neutrophil accumulation was regulated by microbial-derived secondary bile acids. HVEM-deficient mice had reduced ability to deconjugate bile acids during DDC-feeding, suggesting a gut microbiota defect. Consistently, both HVEM and BTLA deficiency had dysregulated intestinal IgA responses targeting the gut microbes. These results suggest that the HVEM-BTLA signaling may restrain liver injury by regulating the gut microbiota.

Citing Articles

Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma.

Yoshikawa S, Taniguchi K, Sawamura H, Ikeda Y, Asai T, Tsuji A Explor Target Antitumor Ther. 2023; 4(4):556-568.

PMID: 37720344 PMC: 10501893. DOI: 10.37349/etat.2023.00152.

References
1.
Murphy K, Nelson C, Sedy J . Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol. 2006; 6(9):671-81. DOI: 10.1038/nri1917. View

2.
Shah R, Kowdley K . Current and potential treatments for primary biliary cholangitis. Lancet Gastroenterol Hepatol. 2019; 5(3):306-315. DOI: 10.1016/S2468-1253(19)30343-7. View

3.
Trauner M, Boyer J . Cholestatic syndromes. Curr Opin Gastroenterol. 2005; 20(3):220-30. DOI: 10.1097/00001574-200405000-00006. View

4.
Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall H, Weiglein A . A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol. 2007; 171(2):525-36. PMC: 1934539. DOI: 10.2353/ajpath.2007.061133. View

5.
Chang S, Kim Y, Kim Y, Kim Y, Moon S, Lee Y . Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice. Front Immunol. 2018; 9:1984. PMC: 6153344. DOI: 10.3389/fimmu.2018.01984. View